Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV001683720 | SCV001159494 | benign | not provided | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001664612 | SCV001876065 | benign | Capillary malformation-arteriovenous malformation 2 | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001664611 | SCV001876067 | benign | Lymphatic malformation 7 | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001683720 | SCV001901354 | benign | not provided | 2019-03-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001683720 | SCV002339486 | benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002400179 | SCV002712965 | benign | Cardiovascular phenotype | 2018-12-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001683720 | SCV005268185 | benign | not provided | criteria provided, single submitter | not provided |